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Synopsis 20 
Objectives Enterobacteriaceae have multiple efflux pumps which confer intrinsic resistance 21 
to antibiotics. AcrB mediates clinically relevant multi-drug resistance and is required for 22 
virulence and biofilm formation making it an attractive target for the design of inhibitors. 23 
The aim of this study was to assess the viability of single transporters as a target for efflux 24 
inhibition using S. Typhimurium as the model pathogen.  25 
Methods The expression of RND efflux pump genes, in response to inactivation of single or 26 
multiple homologues was measured using real-time RT-PCR. Phenotypes of mutants were 27 
characterised by measuring antimicrobial susceptibility, dye accumulation and ability to 28 
cause infection in vitro. 29 
Results Expression of all RND efflux pump genes was increased when single or multiple acr 30 
genes were inactivated, suggesting a feedback mechanism which activates transcription of 31 
homologous efflux pump genes. When two or three acr genes were inactivated, the 32 
mutants had further reduced efflux, altered susceptibility to antimicrobials (including 33 
increased susceptibility to some, but conversely and counter-intuitively, decreased 34 
susceptibility to some others) and were more attenuated in the tissue culture model than 35 
mutants lacking single pumps. 36 
Conclusions These data indicate that it is critical to understand which pumps an inhibitor is 37 
active against and the effect of this on expression of homologous systems. For some 38 
antimicrobials, an inhibitor with activity against multiple pumps will have a greater impact 39 
on susceptibility but, an unintended consequence of this may be decreased susceptibility to 40 
other drugs, such as aminoglycosides. 41 
 42 
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Introduction 43 
Efflux is  an important mechanism of multidrug resistance in bacteria, conferring decreased 44 
susceptibility to a wide range of substrates including antibiotics, dyes, detergents and 45 
biocides.1 This makes them an attractive target for the design of inhibitors which could be 46 
used to potentiate the use of existing antimicrobials.  47 
Resistance nodulation division (RND) efflux transporters are found in the inner membrane of 48 
Gram-negative bacteria and form a complex with an outer membrane channel and a 49 
periplasmic adaptor protein (PAP) to form a tri-partite efflux pump system spanning both 50 
the inner and outer membrane.2, 3 Substrates of these multi-protein complexes are 51 
structurally diverse and include antibiotics, biocides, dyes, detergents and host-derived 52 
molecules. Active efflux of substrates by RND systems is responsible for the intrinsic 53 
resistance of Gram negative bacteria to multiple classes of structurally distinct 54 
antimicrobials.1  55 
Salmonella have five RND efflux pump systems: AcrAB, AcrD, AcrEF, MdtABC and MdsABC. 56 
Further RND efflux pumps are found in some other members of the Enterobacteriaceae 57 
including MdtF in Escherichia coli.4 The transporter protein, AcrB, and its homologues in 58 
other Gram-negative bacteria, is considered the most clinically relevant RND system 59 
because it has the broadest substrate profile and is more abundant within the cell than 60 
other efflux systems.1 Inactivation of acrB increases susceptibility of laboratory mutants of 61 
E. coli, Salmonella enterica and other Enterobacteriaceae to many antimicrobials, whereas 62 
overexpression confers multi-drug resistance (MDR), including to clinically efficacious 63 
agents. Such mutants have been selected in vitro and in vivo.5-8 Efflux via AcrB is driven by 64 
the proton-motive force and forms a tri-partite complex with the PAP, AcrA, and the outer 65 
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membrane channel, TolC.9 The recent elucidation of the structure of AcrB in complex with 66 
different substrates of varying molecular weights has revealed two large, discrete, multisite 67 
binding pockets within AcrB, which may explain how AcrB can transport such structurally 68 
varied substrates. 10, 11  69 
Single deletions of RND efflux pump genes other than acrB have little or no effect on the 70 
susceptibility of Enterobacteriaceae to most antimicrobial agents.12 Antimicrobial 71 
susceptibility of deletion mutants and strains with increased expression of certain RND 72 
efflux pumps indicates that there is overlap, or redundancy between the antimicrobials, 73 
biocides, dyes and detergents that can be transported by the different RND pumps of 74 
Salmonella.12, 13 AcrF is the closest homologue of AcrB in Salmonella (80% identity) and 75 
AcrEF overexpression can suppress antibiotic hyper-susceptibility in AcrB deficient strains.12, 76 
13 AcrD (64% identity to AcrB) and MdtABC have similar substrate profiles including SDS, 77 
novobiocin, deoxycholate, some β-lactams, copper and zinc.12, 14 In E. coli and Salmonella, 78 
AcrD also transports aminoglycoside antibiotics.15, 16 MdsABC is found only in Salmonella 79 
and in LB medium is expressed at lower levels than the other four RND efflux pumps.17 80 
However, overexpression of mdsAB, encoding the pump and periplasmic adaptor  protein, 81 
or MdsABC, encoding all three components, were overexpressed in a strain lacking AcrB, 82 
susceptibility to novobiocin, acriflavine, crystal violet, methylene blue, rhodamine 6G, 83 
benzalkonium chloride and SDS was decreased compared to the mutant suggesting that 84 
MdsB is capable of exporting these compounds.18  85 
In addition to the role in resistance to antimicrobials, some RND efflux pumps are also 86 
required for virulence of many Gram-negative pathogens.19 In S. Typhimurium, inactivation 87 
of acrB attenuated invasion of tissue culture cells in vitro and colonisation in poultry.20, 21 88 
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Inactivation of acrAB or acrEF has also been shown to attenuate the virulence of the 89 
organism in mice.12 90 
Regulation of RND efflux pumps is complex; transcriptional control is multi-layered and 91 
some regulators control expression of more than one pump. In Salmonella and E. coli, the 92 
regulation of acrAB is the best studied. The acrA and acrB genes are encoded in a single 93 
operon and are co-regulated. At a local level acrAB is repressed by AcrR, which is encoded 94 
alongside and divergently transcribed from acrAB. At a global level members of the 95 
AraC/XylS family of DNA transcriptional activators, such as MarA, SoxS, Rob and RamA, all 96 
influence expression of acrAB-tolC and have overlapping recognition sites.22-27 AcrD and 97 
MdtABC are both under the control of the two-component regulatory systems BaeSR and 98 
CpxAR which induce expression of AcrD and MdtABC in response to high levels of indole, 99 
copper, zinc or envelope stress.28, 29 Expression of acrEF in E. coli is generally low due to 100 
repression by the global regulator H-NS.30 However, acrEF is also encoded alongside a gene 101 
encoding a local repressor, AcrS (previously EnvR) which inhibits expression of acrAB and 102 
acts as a regulatory switch between expression of acrAB and acrEF.31 103 
Due to the functional redundancy of RND pumps, potential exists for the loss of certain 104 
pump components to be compensated by increased expression of a homologous 105 
component that could fulfil, at least to some extent, the same function. For example, Eaves 106 
and colleagues 32 showed that when acrB or acrF of Salmonella was inactivated, expression 107 
of acrD increased (3.6 and 4.9 fold, respectively). To allow compensatory changes in 108 
expression levels of efflux systems upon inactivation of homologous systems, there must be 109 
a tightly controlled and integrated regulatory network that can respond to loss of efflux 110 
function. Whilst the literature contains multiple examples of regulation of single efflux 111 
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systems or a small number of efflux systems, an integrated network of regulation is yet to 112 
be elucidated. 113 
The role of RND systems in both antimicrobial resistance and virulence makes them 114 
attractive targets for the design of inhibitors. Using S. Typhimurium as a model, the aim of 115 
the present study was to investigate the viability of single transporters such as AcrB as a 116 
target for efflux inhibition by investigating the expression and roles of structurally similar 117 
efflux pumps in antimicrobial resistance and virulence, and the extent of the redundancy 118 
between RND efflux pumps. This information is crucial for the rational design of inhibitors 119 
which inhibit all pumps so preventing resistance by compensatory over-production of 120 
homologous RND efflux systems.  121 
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Materials and Methods 122 
Strains and growth conditions. All strains were derived from Salmonella enterica serovar 123 
Typhimurium SL1344.33 Salmonella was used as a model organism in this study as it is an 124 
important human pathogen that causes a significant number of infections annually. SL1344 125 
is a widely studied pathogenic strain of Salmonella for which there are well validated 126 
models of infection including an in vitro tissue culture model. Single gene inactivated 127 
mutants were constructed as described previously.32, 34 Mutants with multiple efflux pumps 128 
inactivated were created by P22 transduction between mutants in which single genes were 129 
inactivated or deleted. All mutants were verified by PCR and DNA sequencing. All 130 
experiments including MICs reveal that the phenotype of the marked and unmarked 131 
mutants for the same gene is indistinguishable. LB broth (Sigma-Aldrich, UK) and MOPS 132 
minimal medium (Teknova Inc., USA) were used throughout this study. 133 
RNA extraction and Real Time qRT-PCR. Overnight cultures of S. Typhimurium SL1344 and 134 
the test strains were grown in MOPS minimal medium at 37°C. From each strain three 135 
biological replicate RNA preparations were made and quantified as described previously.22, 136 
35 Primers (Supplementary Table 1) were designed with an annealing temperature of 57.3˚C 137 
using Beacon Designer 4.0 (Premier Biosoft, USA). cDNA was synthesised from 2 µg total 138 
RNA using superscript III cDNA synthesis kit (Invitrogen). Validation experiments were 139 
carried out using 5 cDNA standards of different concentrations (10, 1, 0.1, 0.01, 0.001 ng/µl) 140 
to determine PCR efficiency for the housekeeping gene 16S and each test gene. qRT-PCRs 141 
were set up in biological triplicate and technical duplicate in a BIORAD PCR tray using 1 µl 142 
neat cDNA for test genes and 1 µl of a 1:1000 dilution cDNA for 16S in a 25 µl reaction 143 
containing 12.5 µl iQ SYBR green supermix (BIORAD, UK), 1 µl primers (500nm) and 9.5 µl 144 
8 
 
sterile water. qRT-PCR was carried out in a CFX-96 Real-time machine (BIORAD, UK) using 145 
the following protocol; 95˚C for 5 minutes followed by 40 plate read cycles of 95˚C for 30 s, 146 
57.3˚C for 30 s and 72˚C for 30 s. Data were analysed using CFX Manager (BIORAD, UK) and 147 
expression ratios were calculated using the ∆∆ct method and normalised to expression of 148 
16S.36 149 
Determination of susceptibility to antimicrobials. Biolog data was confirmed by measuring 150 
growth in the presence of representative AcrB substrates. Briefly, overnight bacterial 151 
cultures were diluted to 104 CFU/ml and grown in a 96 well plate in iso-sensitest broth in the 152 
presence of selected drugs at 0.25 x the wild-type MIC.  153 
The minimum inhibitory concentrations (MIC) of antibiotics, dyes and detergents were 154 
determined for each strain according to the standardised agar doubling dilution method 155 
procedure of the British Society of Antimicrobial Chemotherapy (BSAC) using iso-sensitest 156 
agar.37 The MIC was determined as the lowest concentration of antimicrobial that caused no 157 
visible growth. Values stated are the mode value from at least three biological replicates 158 
performed on at least three independent occasions. All antimicrobials tested were obtained 159 
from Sigma, UK. 160 
Accumulation of Hoechst 33342 and norfloxacin. The efflux activity of the mutants was 161 
assessed by determining the accumulation of the fluorescent dye Hoechst 33342 and 162 
norfloxacin (Sigma, UK) as described previously.38, 39 Differences in steady state 163 
accumulation values between mutants and parental strains were analysed for statistical 164 
significance using a two-tailed Student's t-test, where P < 0.05 was considered significant. 165 
Data presented are the mean of three independent biological replicates ± standard error of 166 
the mean. 167 
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Adhesion and invasion assays. The ability of the strains to adhere to, and invade, INT-407 168 
(human embryonic intestine cells) was measured as previously described.21 Each assay was 169 
repeated a minimum of three times, with each experiment including four technical 170 
replicates per bacterial strain. The results were analysed using Student’s t-test and P values 171 
of ≤ 0.05 were considered significant. 172 
  173 
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Results 174 
In silico analysis 175 
The Salmonella genome encodes five efflux systems of the RND family. The three most 176 
similar pump proteins are AcrB, AcrD and AcrF (Table 1). The two remaining RND pumps, 177 
MdsB and MdtB/C, which is a heteromultimer of MdtB and MdtC, are 46.7% and 48.6% 178 
identical to AcrB, respectively.  ClustalW alignments of all six RND type proteins revealed 179 
that five residues (Asp407, Asp408, Lys940, Arg971 and Thr978) vital to proton transport 180 
within AcrB of E. coli 40, 41 are identical in all six Salmonella proteins indicating that energy 181 
transduction is conserved in this family of proteins. However, greater variation was seen in 182 
residues involved in substrate recognition or binding. For example, of six important residues 183 
in the hydrophobic, phenylalanine rich binding pocket of AcrB (Phe178, 615, 610, 136, 617 184 
and 628) 42 all six were conserved in AcrF, two in AcrD, one in MdtC, one in MdsB and none 185 
of these residues were found in MdtB.  186 
Expression of efflux pump genes is altered upon inactivation of homologous pumps.  187 
To determine whether the expression of each gene was altered upon inactivation of one or 188 
more homologous genes, real-time quantitative RT-PCR was used to measure the level of 189 
acrB, acrD and acrF transcription in the single, double and triple efflux mutants compared to 190 
SL1344 (Table 2). As shown previously, in the acrB mutant both acrD and acrF had increased 191 
expression.32 In the acrD mutant, expression of acrB was increased while acrF expression 192 
was unchanged. In the acrF mutant both acrB and acrD had increased expression. The 193 
expression of mdsB and mdtB, was also affected by loss of single RND pumps.  The 194 
expression of mdtB was increased in the acrF mutant while expression of the Salmonella 195 
specific efflux pump mdsB was decreased upon inactivation of acrB, acrD or acrF (Table 2). 196 
11 
 
When two genes were inactivated (e.g. acrB and acrF or acrB and acrD) expression of acrD 197 
or acrF was increased, although expression was lower than in the strain lacking only acrB 198 
(L110). When acrF and acrD were inactivated expression of acrB was increased, this was 199 
greater than that seen upon inactivation of acrD and similar to that in the acrF mutant. 200 
Expression of the mdtB and mdsB efflux genes was increased in all acr gene double mutants 201 
(L646, L1297 and L1395) but in the triple acrBDF mutant only mdtB expression was 202 
increased. Expression of both mdtB and mdsB was highest in the acrDF mutant (L1395) 203 
(Table 2). 204 
The expression level of known regulators of RND efflux was also measured. The expression 205 
of ramA and marA was increased when acrB was inactivated but not changed in the acrD 206 
(L132) or acrF (L131) mutants (Table 2). Expression of soxS was increased in the acrBF 207 
mutant (6.3 fold), in the acrDF mutant (2.2 fold) and in the strain lacking all three RND pump 208 
genes. Expression of rob was not significantly altered in any of the mutants. The expression 209 
of the genes encoding the repressor proteins AcrR and EnvR/AcrS was also measured. 210 
Transcription of acrR was decreased in the acrB mutant and transcription of envR was 211 
increased in the acrBDF mutant (Table 2). 212 
 213 
Inactivation of two or more RND efflux systems altered antimicrobial susceptibility. 214 
 As previously described, inactivation of acrB led to multi-drug hyper-susceptibility while 215 
single inactivation of either acrD or acrF did not significantly alter MICs of antibiotics, dyes 216 
and detergents compared to the wildtype strain. Re-interrogation of previously published 217 
data 43 from the Biolog Phenotype Microarray showed that the acrD and acrF mutants grew 218 
better than SL1344 when exposed to four β-lactams, five macrolides, and five quinolones 219 
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(Supplementary Table S2). This observation was confirmed by measuring the growth kinetics 220 
of the strains in the presence of representative AcrB substrates. However, the beneficial 221 
effect of lacking acrD or acrF was lost when acrB was deleted in the same strain (L1297 and 222 
L646, respectively) (Figure 1). 223 
The antimicrobial susceptibility of the double mutant lacking AcrD and AcrF (L1395) was not 224 
significantly different from that of SL1344 (Table 3). Furthermore, except for ethidium 225 
bromide (for which the MIC value was lower) and the aminoglycosides (for which the MIC 226 
values were increased), the susceptibility of the acrBD (L1297), acrBF (L646) and the triple 227 
acrBDF (L1405) mutants to antibiotics, dyes and detergents was not significantly different to 228 
that of the acrB mutant. Surprisingly, the MICs of the aminoglycoside antibiotics, 229 
streptomycin, gentamicin and amikacin, were higher for the acrBF (L646) mutant and the 230 
triple acrBDF mutant (L1405) than for the wild-type parental strain SL1344; the MIC of 231 
tobramycin was also greater for L1405 than SL1344 (Table 3B). All acrB mutants (L110, L646, 232 
L1297 and L1405) were more susceptible to the efflux inhibitors Phe-arg-β-naphthylamide 233 
(PAβN) and carbonyl cyanide m-chlorophenyl hydrazone (CCCP) than the wild-type parental 234 
strain (SL1344). 235 
Inactivation of two or more RND efflux systems decreased efflux activity.  236 
We previously showed that inactivation of acrB led to increased accumulation of the dye 237 
Hoechst 33342.20 Compared to SL1344, inactivation of acrD (L132) or acrF (L131) or 238 
inactivation of both acrD and acrF (L1395) did not significantly alter the accumulation of 239 
Hoechst 33342 (Figure 2). However, mutants with acrB and another acr gene inactivated 240 
(acrBD (L1297) or acrBF (L646)) accumulated less Hoechst 33342 than the acrB mutant. The 241 
acrBDF mutant (L1405) accumulated the highest level of Hoechst 33342 indicating the 242 
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lowest level of efflux. Accumulation of the fluoroquinolone antibiotic, norfloxacin, showed a 243 
similar pattern although the acrB mutant accumulated a higher concentration than the 244 
acrBDF mutant (Figure 3). 245 
Inactivation of two or more RND efflux systems attenuated the ability of Salmonella to 246 
infect tissue culture cells.   247 
In addition to their role in antimicrobial resistance, in many Gram-negative bacterial 248 
pathogens RND efflux pumps are required for the ability to cause infection.19 Inactivation of 249 
acrB has been previously shown to attenuate invasion of S. Typhimurium into mammalian 250 
cells growing in tissue culture.12, 20, 21 We now show that single gene inactivation of either 251 
acrD (L132) or acrF (L131) also significantly attenuate the virulence of Salmonella. Adhesion 252 
by L131 (acrF::aph) to human intestinal cells (INT-407) was 56.0% that of SL1344 and it only 253 
invaded at 39.1% of wild-type level. L132 (acrD::aph) was even more attenuated; adhesion 254 
was only 29.0% that of SL1344 and invasion was only 39.1% of the SL1344 level (Figure 4). 255 
When two efflux pump genes were inactivated or deleted, the ability of Salmonella to 256 
adhere to, and invade, INT-407 cells was attenuated more than that seen in single acr 257 
mutants (Figure 4). Invasion of the acrBD double mutant was the lowest among all single 258 
and double mutants at only 0.4% of wild-type level. The adhesion of the acrDF mutant, 259 
L1395 (acrD::cat, acrF::aph), was 83.7% that of SL1344 adhesion, which is significantly 260 
greater than mutants lacking only one of these systems. Despite this, the invasion level of 261 
this mutant was only 17.8% that of the parental strain showing that these two mutations 262 
have an additive effect upon invasive ability. When all three of the efflux genes were 263 
inactivated in L1405, Salmonella was almost completely unable to adhere to or invade INT-264 
407 cells (adhesion = 0.16% of wild-type level, invasion = 0.004% of wild-type level).  265 
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Discussion 266 
The role of RND efflux pumps in multi-drug resistance and virulence makes them attractive 267 
targets for the design of efflux inhibitors. We have shown that expression of all RND efflux 268 
pump genes can be altered when single or multiple acr genes are inactivated. These data 269 
suggest that the bacterium can sense and respond to the levels of RND transporters and due 270 
to overlapping substrate specificity this affords resilience to the bacterium to prevent 271 
intracellular accumulation of toxic metabolites,44-47 or survival in toxic environments.  272 
Critically, we can correlate alteration in efflux level and sensitivity to antimicrobials to the 273 
compensatory changes in efflux pump gene expression in strains lacking specific RND 274 
pumps. For example, in the Biolog phenotype microarray many of the compounds in which 275 
the acrD and acrF mutant grew better are known substrates of AcrB which is over-expressed 276 
in these mutants. Furthermore, this beneficial effect is lost when acrB is also inactivated. 277 
Other than to the aminoglycosides, the susceptibility of the acrBD and acrBF mutants was 278 
not significantly different to that of the mutant lacking only acrB and it is likely that this is 279 
because the other three RND systems are overproduced in both cases.  280 
AcrD, which is known to transport aminoglycosides, and MdtB, which has a similar substrate 281 
profile to AcrD, are over-expressed in the acrBF mutant. This could explain the decreased 282 
susceptibility to the aminoglycosides seen in this mutant. The acrBDF mutant also had 283 
decreased susceptibility to the aminoglycosides. Expression of mdsB is increased in this 284 
mutant but there is currently no evidence this pump can transport aminoglycosides. 285 
Aminoglycosides enter bacterial cells by self-promoted uptake and it is possible that 286 
changes in expression of genes encoding cell envelope components, including LPS,  could be 287 
responsible for this effect.48  288 
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These data provide proof of principle that changes in expression of pumps in response to 289 
inactivation of RND efflux pumps can alter susceptibility to clinically relevant antimicrobials. 290 
We postulate the same will be true when the pump proteins themselves are inhibited and 291 
recent evidence showing that the efflux inhibitors PAβN and NMP altered expression of RND 292 
efflux pump genes in E. coli supports this.49  Additionally, this highlights that any change in 293 
the phenotype of strains with single or multiple genes inactivated should be interpreted 294 
with caution as the phenotype represents, the engineered inactivation and any consequent 295 
transcriptional changes. 296 
The role of AcrAB-TolC in virulence of S. Typhimurium is well established and inactivation of 297 
acrB causes decreased expression of genes in SPI-1, which are known to be required for 298 
infection.12, 20, 21, 35 Nishino et al., showed that inactivation of acrD did not confer significant 299 
attenuation in the BALB/C mouse model of infection and inactivation of acrEF (encoding the 300 
RND pump protein and the periplasmic adaptor protein) increased the host survival rate 301 
with 20% of mice surviving to 21 days rather than none when infected with the wild-type 302 
strain.12 In the tissue culture model lack of either AcrD or AcrF caused a significant reduction 303 
in the ability of Salmonella to infect INT-407 cells with the acrD mutant (L132) being more 304 
attenuated than the acrF mutant (L131). There are several hypotheses to explain these data. 305 
First, as inactivation of acrB is known to alter expression of genes found in SPI-1 35 it is 306 
possible that inactivation of other RND pump genes also affects virulence gene expression. 307 
Alternative explanations include that RND efflux pumps export substrates that are required 308 
for infection or that absence of some RND efflux pumps causes damage or stress to the 309 
bacterial cell membrane which compromises the ability to cause infection.  310 
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The effect of inactivating acrB plus one or two other efflux pump genes upon the ability to 311 
cause infection was additive. The acrDF (L1395) mutant was less attenuated than either of 312 
the single mutants (L131 and L132). One explanation for this is that acrB, mdtB and mdsB 313 
are all overexpressed in this mutant and so are able to partially compensate for the 314 
functions of the other two systems. The triple mutant lacking AcrB, AcrD and AcrF was 315 
unable to adhere to, or invade the INT-407 cells. This could suggest that no other 316 
transporter could compensate for the loss of these proteins or that inactivation of multiple 317 
RND efflux pump genes causes greater changes in expression of virulence genes. 318 
The role of efflux pumps in antibiotic resistance makes them targets for the design of 319 
inhibitors. Due to the role of efflux pumps in virulence we also postulate that efflux 320 
inhibitors will inhibit virulence as well as augment the activity of antibacterial drugs. Our 321 
data show that inhibitors designed to inhibit all RND efflux systems will have a greater anti-322 
virulence effect on the organism.  323 
The compensatory expression of efflux pump genes was associated with changes in 324 
regulatory gene expression. We hypothesise that the bacterial cell is attempting to increase 325 
expression of the inactivated/deleted genes by increasing expression of factors known to 326 
regulate expression of RND efflux pump genes such as ramA, marA, soxS and rob.22-24, 26, 27, 327 
43, 50 Our data suggest that these regulators are involved in the modulation of RND efflux 328 
pump expression in the absence of homologous systems. Expression of ramA was increased 329 
when acrB was inactivated,51 however, expression of soxS was increased when two or more 330 
acr genes were inactivated. SoxS is also a transcription factor of the AraC/XylS family 331 
involved in regulating the response to oxidative stress and genes including acrAB and micF.52 332 
Increased expression of soxS could suggest that lack of efflux by Acr pump proteins leads to 333 
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accumulation of toxic metabolites, as proposed by Rosner and Martin when E. coli tolC is 334 
inactivated.44, 47 335 
The critical role of RND systems in both antimicrobial resistance and virulence of pathogenic 336 
bacteria makes them attractive targets for the design of inhibitors. These molecules could 337 
be used to re-sensitise the bacterium to antimicrobials whilst simultaneously attenuating 338 
virulence of the infecting organism. Critically, our data indicate that care should be taken 339 
when developing efflux pump inhibitors against the RND pumps to determine which pumps 340 
are inhibited and to understand the effect of this on expression of homologous systems. In 341 
terms of attenuating virulence, the effect of inhibition was additive so inhibition of multiple 342 
pumps is a good strategy. However, the benefit of this strategy on increasing susceptibility 343 
to antimicrobials may be more complex and the impact of this will depend on which drugs 344 
are used to treat infections by a particular pathogen. For some antimicrobials, an inhibitor 345 
with activity against multiple pumps will have a greater impact on susceptibility but, an 346 
unintended consequence of this may be decreased susceptibility to other drugs, such as the 347 
aminoglycosides. 348 
  349 
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Figure legends 358 
Figure 1. Growth of efflux pump mutants in the presence of AcrB substrates. Growth of the 359 
efflux in the presence of (a) ciprofloxacin and (b) doxycycline at a concentration of 0.25 x 360 
the MIC for wild-type. Data presented is the mean of three biological replicates. 361 
Figure 2. Hoechst 33342 Accumulation in (A) single efflux mutants and (B) double and 362 
triple efflux mutants. The data presented are the mean of three separate experiments 363 
presented as fold change compared to SL1344 at the end point of the assay ± standard error 364 
of the mean. Student’s t-tests were performed to compare the Hoechst 33342 accumulation 365 
of each strain to that of SL1344 and those returning P values of less than 0.05 are indicated 366 
by *.  367 
Figure 3. Accumulation of norfloxacin. Data shown is the mean of three biological replicates 368 
+/- the standard error of the mean. 369 
Figure 4. Adhesion (A) and Invasion (B) of strains lacking AcrB, AcrD, AcrF and 370 
combinations thereof to invade INT-407 cells in vitro. Data shown is the mean of at least 371 
three independent experiments. Student’s t-tests were used to compare values for each 372 
strain with that of the wild-type, SL1344. P values of ≤ 0.05 were considered significant and 373 
are indicated by asterisks. 374 
  375 
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Figure 1.  376 
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Figure 2. Hoechst 33342 accumulation 379 
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Figure 3. Accumulation of norfloxacin 382 
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Figure 4. Adhesion (A) and Invasion (B) of strains lacking AcrB, AcrD, AcrF and 385 
combinations thereof to invade INT-407 cells in vitro 386 
 387 
  388 
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Table 1. Percentage nucleotide identity and amino acid similarity between RND efflux 389 
pump genes and proteins of Salmonella  390 
 acrB / 
AcrB 
acrD / 
AcrD 
acrF / 
AcrF 
mdtB / 
MdtB 
mdtC / 
MdtC 
mdsB / 
MdsB 
acrB/AcrB - 70 / 79.1 74 / 90.4 55 / 46.7 55 / 48.6 59 / 63.4 
acrD/AcrD - - 68 / 78.2 54 / 49.1 54 / 48.8 59 / 61.3 
acrF/AcrF - - - 54 / 47.4 53 / 48.5 57 / 63.1 
mdtB/MdtB - - - - 62 / 66.0 56 / 49.0 
mdtC/MdtC - - - - - 56 / 49.2 
mdsB/MdsB - - - - - - 
 391 
  392 
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Table 2. Expression of RND efflux pump genes and regulators thereof, quantified by real time RT-PCR  
  Fold change in gene expression   
  RND efflux pump genes Known regulators of efflux 
Strain   acrB acrD acrF mdtB mdsB marA ramA rob soxS acrR envR 
SL1344 WT 1.0 1.00 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 
L644 ΔacrB - 13.4 16.0 1.0 0.6 2.0 2.8 1.4 2.6 0.4 1.2 
L132 acrD::aph 1.8 - 1.0 0.9 0.5 1.2 0.8 1.4 1.3 0.3 0.6 
L131 acrF::aph 3.4 3.4 - 1.8 0.7 0.9 1.0 1.3 1.4 0.9 1.5 
L646 ∆acrF acrB::aph - 4.6  4.5 3.0 2.5 1.6 1.2 6.3 0.4 0.8 
L1297 ΔacrB  acrD::aph - - 2.4 4.6 2.1 1.2 1.4 1.1 1.8 2.2 1.2 
L1395 ΔacrF acrD::aph 3.8 - - 6.0 5.9 1.0 1.3 1.4 2.2 0.4 1.0 
L1405 ∆acrB ∆acrF 
acrD::aph 
- - - 1.1 3.2 1.6 1.9 1.0 5.0 0.5 4.5 
Bold text indicated statistically significant (P ≤0.05) increased expression. Italic text indicates statistically significant decreased expression.
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Table 3. Antimicrobial susceptibility of SL1344 and RND mutants thereof.  
A. Minimum Inhibitory Concentration of antimicrobials to SL1344 and mutants thereof. 
 
 MIC (mg/L) 
 
 
Genotype Amp Chl Cip Tet Nal EtBr Fus Ami Gent Hyg Strep Tob PAβN CCCP 
 
SL1344 Wild-type  2 4 0.015 1 4 >256 >256 4 0.5 32 8 2 >1024 64 
 
L110 acrB::aph 0.25 1 <0.008 0.5 1 64 8 4 1 32 8 1 64 32 
 
L644 ΔacrB 0.25 1 <0.008 0.5 1 64 8 4 1 32 8 1 64 32  
L131 acrF::aph 2 4 0.015 2 4 >256 >256 4 1 32 16 2 >1024 64 
 
L132 acrD::aph 2 4 0.015 1 4 >256 >256 4 1 32 16 2 >1024 64 
 
L646 ∆acrF acrB::aph 2 1 <0.008 1 1 16 4 8 2 64 32 4 64 32 
 
L1297 ΔacrB acrD::aph 0.25 1 <0.008 0.5 1 64 8 2 0.5 32 8 1 64 32 
 
L1395 acrF::cat acrD::aph 2 16 0.015 2 4 >256 >256 4 1 64 16 2 >1024 64 
 
L1405 ∆acrB ∆acrF acrD::aph 0.12 1 <0.008 0.5 1 16 8 16 2 64 32 8 64 32 
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B. Fold change in MIC compared to ΔacrB (L644)  
 
Genotype Amp Chl Cip Tet Nal EtBr Fus Ami Gent Hyg Strep Tob PAβN CCCP 
L646 ∆acrF acrB::aph 4   2  -4 -2 2 2 2 4 4   
L1297 ΔacrB acrD::aph        -2 -2 -2     
L1405 ∆acrB ∆acrF acrD::aph -2     -4  4 2 2 4 8   
 
Amp, ampicillin; Chl, chloramphenicol; Tet, tetracycline; Nal, nalidixic acid; EtBr, Ethidium bromide; Fus, Fusidic Acid; Ami, Amikacin, Gent, 
Gentamicin; Hyg, Hygromycin; Strep, Streptomycin; Tob, Tobramycin; PAβN, Phe-Arg β-naphthylamide dihydrochloride; CCCP, Carbonyl 
cyanide 3-chlorophenylhydrazone. The aph gene used is aph(3’)-1 which gives resistance to kanamycin, neomycin and paromycin.  
Table 3A: Bold red font indicates an increase in the MIC of the same compound compared to SL1344. Italic blue font indicates a decrease in the 
MIC of the same compound compared to SL1344.  Table 3B: Bold red font indicates an increase in MIC compared to the same compound for 
L644. Italic blue font indicates a decrease in the MIC of the same compound for ΔacrB. No value indicates no difference in MIC values.
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